TITLE:
A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

CONDITION:
Multiple Myeloma

INTERVENTION:
Motexafin Gadolinium Injection

SUMMARY:

      The purpose of the study is to determine if the drug motexafin gadolinium will be an
      effective treatment for patients who have relapsed or refractory multiple myeloma.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Relapsed or Refractory Multiple Myeloma

          -   18 years old

          -  Able to provide consent for participation

          -  ECOG status 0-2

        Lab values:

          -  ANC  1,000/L

          -  WBC count  2.0/L

          -  Hemoglobin  8.0 g/dL

          -  Platelet count  50,000/L

          -  AST and ALT  2 x ULN

          -  Total Bilirubin  2 x ULN

          -  Creatinine  2.0 mg/dL

        and

          -  Not pregnant or lactating
      
